![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/spacer.gif)
yttrium Y 90 humanized epratuzumab A radioimmunotherapeutic humanized murine monoclonal antibody (LL2) directed against the CD22 pan-B-cell antigen and chelated to the radioisotope yttrium-90 (Y 90). Y 90 humanized monoclonal antibody LL2 binds to tumor cells expressing CD22, delivering a cytotoxic dose of beta radiation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/spacer.gif)
Synonyms: | ![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/spacer.gif) | Y 90 epratuzumab Y 90 Humanized Monoclonal Antibody LL2 Y 90 monoclonal antibody LL2 Y90 Humanized Epratuzumab Yttrium Y 90 Humanized Monoclonal Antibody LL2 yttrium Y 90 MOAB LL2 yttrium Y-90 epratuzumab | | ![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/spacer.gif) | Abbreviation: | ![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/spacer.gif) | Y90 MOAB LL2 | | ![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090115054010im_/http://www.cancer.gov/images/spacer.gif) |